Optimi Health Stock Price, News & Analysis (OTCMKTS:OPTHF) $0.12 +0.01 (+5.24%) (As of 12/8/2023 02:50 PM ET) Add Compare Share Share Today's Range$0.12▼$0.1250-Day Range$0.11▼$0.1452-Week Range$0.11▼$0.22Volume5,750 shsAverage Volume15,039 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest About Optimi Health Stock (OTCMKTS:OPTHF)Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.Read More OPTHF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPTHF Stock News HeadlinesDecember 7, 2023 | finance.yahoo.comOptimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply AgreementNovember 28, 2023 | finance.yahoo.comOptimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability TestingDecember 9, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 23, 2023 | morningstar.comOptimi Health Corp OPTHFNovember 10, 2023 | finanznachrichten.deOptimi Health Corp.: Optimi Health Resolves DisputeNovember 10, 2023 | finance.yahoo.comOptimi Health Resolves DisputeNovember 7, 2023 | finance.yahoo.comOptimi Health Welcomes Dr. Preston A. Chase as New Chief Science OfficerNovember 2, 2023 | nz.finance.yahoo.comLi Keqiang: Chinese leader's hometown mourns his deathDecember 9, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 2, 2023 | finance.yahoo.comOptimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt FinancingSeptember 15, 2023 | proactiveinvestors.comPsychedelics CEOs heartened by MDMA for PTSD study results as stocks maintain momentumSeptember 14, 2023 | finance.yahoo.comOptimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical TrialSeptember 8, 2023 | benzinga.comOptimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private FinancingSeptember 7, 2023 | finance.yahoo.comOptimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access ProgramSeptember 5, 2023 | finance.yahoo.comOptimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt FinancingAugust 10, 2023 | finance.yahoo.comOptimi Health Announces CAD $3,000,000 Senior Debt FinancingAugust 1, 2023 | finance.yahoo.comOptimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional PatentJuly 27, 2023 | finance.yahoo.comOptimi Health Announces Receipt of Purported Termination NoticeJuly 12, 2023 | finance.yahoo.comOPTHF - Optimi Health Corp.June 20, 2023 | benzinga.comMDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian UniversityJune 15, 2023 | finance.yahoo.comOptimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPSMay 17, 2023 | finance.yahoo.comOptimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical MarketMay 11, 2023 | msn.comOptimi Health Boosts Psilocybin Production With New Health Canada License And Supply DealMay 10, 2023 | finance.yahoo.comOptimi Health Granted Natural Health Product Site Licence By Health CanadaMay 10, 2023 | finance.yahoo.comOptimi Health Granted Natural Health Product Site Licence By Health CanadaMay 4, 2023 | finance.yahoo.comOptimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and DevelopmentApril 5, 2023 | markets.businessinsider.comWhat To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging IndustrySee More Headlines Receive OPTHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Farm Products Sub-IndustryN/A SectorConsumer Defensive Current SymbolOTCMKTS:OPTHF CUSIPN/A CIKN/A Webwww.optimihealth.ca PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. John James Wilson (Age 33)Co-Founder & Non-Executive Chairman Comp: $72.34kMr. William J. Ciprick (Age 46)Chief Executive Officer Comp: $255.77kMr. Bryan Edward Safarik (Age 38)Co-Founder, COO & Director Comp: $54.81kMr. Jacob Safarik (Age 36)Co-Founder, CFO & Director Comp: $57.73kMr. Dane Stevens (Age 34)Co-Founder, Chief Marketing Officer & Director Comp: $56.27kDr. Preston A. ChaseChief Science OfficerLaura ChowDirector of Products & SalesMs. Ann LittleHuman Resources ManagerMs. Leah Hodges (Age 39)Corporate Secretary More ExecutivesKey CompetitorsAgriFORCE Growing SystemsNASDAQ:AGRIWAstral FoodsOTC:ALFDFAtlantic Sapphire ASAOTC:AASZFAustevoll Seafood ASAOTCMKTS:ASTVFCalifornia OrchardOTC:CAOXView All Competitors OPTHF Stock Analysis - Frequently Asked Questions How have OPTHF shares performed in 2023? Optimi Health's stock was trading at $0.1747 at the start of the year. Since then, OPTHF stock has decreased by 29.9% and is now trading at $0.1225. View the best growth stocks for 2023 here. Are investors shorting Optimi Health? Optimi Health saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 900 shares, a decline of 78.6% from the October 31st total of 4,200 shares. Based on an average daily volume of 22,500 shares, the days-to-cover ratio is presently 0.0 days. View Optimi Health's Short Interest. How do I buy shares of Optimi Health? Shares of OPTHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:OPTHF) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.